Intelligence Platform
Patents
Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9896509
Use of antagonists of the interaction between HIV GP120 and α4β7 integrin
granted patentUS 9896484
Influenza virus recombinant proteins
granted patentUS 9890369
Cytolethal distending toxin subunit B conjugated or fused to Bacillus anthracis toxin leth
granted patentUS 9889115
Fitness assay and associated methods
granted patentUS 9884104
Live attenuated virus vaccines for la crosse virus and other bunyaviridae
granted patentUS 9884100
Lutzomyia longipalpis polypeptides and methods of use
granted patentUS 9879231
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertio
granted patentUS 9879065
T cell receptors recognizing MHC class II-restricted MAGE-A3
granted patentUS 9878972
Compounds and methods for delivery of prostacyclin analogs
granted patentUS 9873893
Methods and compositions for treating genetically linked diseases of the eye
granted patentUS 9873702
Heterocyclic compounds as biogenic amine transport modulators
granted patentUS 9868954
Reduction of TGFβ signaling in myeloid cells in the treatment of cancer
granted patentUS 9868943
Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA
granted patentUS 9868774
Anti-CD22 chimeric antigen receptors
granted patentUS 9868769
Mutated Salmonella enteriaca
granted patentUS 9867830
Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydr
granted patentUS 9862679
Potent and selective inhibitors of monoamine transporters; method of making; and use there
granted patentUS 9861681
Therapeutic compositions for neutralizing type I interferons, and methods of use
granted patentUS 9856453
Compositions and methods for prevention or treatment of neoplastic disease in a mammalian
granted patentUS 9856313
Epitope of RSV fusion protein and antibody recognizing the same
granted patentUS 9856204
Methods for inhibiting muscle atrophy
granted patentUS 9855330
Granulysin in immunotherapy
granted patentUS 9855312
GHRH agonists for the treatment of ischemic disorders
granted patentUS 9855298
Methods of conditioning patients for T cell therapy
granted